Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Oct 26;83(10):1323–1329. doi: 10.1054/bjoc.2000.1442

Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer

R Rosenberg 1, A Hoos 1, J Mueller 1, H Nekarda 1
PMCID: PMC2408777  PMID: 11044357

Abstract

The reported rates for tumour cell involvement in the locoregional lymph nodes of colorectal cancer vary greatly, depending on the method used and case selection. In order to further evaluate the clinical value of molecular biologic detection of tumour cells we investigated 102 histologically tumour-free (pN0) regional lymph nodes from 51 consecutive, completely resected (UICC R0) colorectal carcinoma specimens for the presence of tumour cell mRNA by RT-PCR specific for carcinoembryonic antigen (CEA) and cytokeratin 20 (CK-20). Two lymph nodes located nearest to the primary tumour were investigated in each case. CK-20 mRNA was found in 31 of 51 patients (60.8%) and CEA mRNA in 30 of 51 patients (58.8%), respectively. Identical transcription patterns of CK-20 and CEA mRNA (both positive or both negative) were found in 38 of 51 patients (74.5%). There was a significantly higher proportion of cases with CEA positivity in the lymph nodes of tubulopapillary than of mucinous adenocarcinomas (P< 0.03). Detection of CK-20 and CEA mRNA correlated in nine of 12 cases (75.0%) with the risk of tumour recurrence (not significant) and showed a tendency towards shorter disease-free survival by univariate analysis (not significant). Our data indicate that CK-20 and CEA mRNA detection by RT-PCR may prove useful for the prediction of tumour recurrence of patients with pN0 colorectal carcinoma, although neither reach statistical significance in this series of patients. © 2000 Cancer Research Campaign

Keywords: colorectal cancer, CEA, CK-20, RT-PCR, tumour cell involvement, prognosis

Full Text

The Full Text of this article is available as a PDF (104.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calaluce R., Miedema B. W., Yesus Y. W. Micrometastasis in colorectal carcinoma: a review. J Surg Oncol. 1998 Mar;67(3):194–202. doi: 10.1002/(sici)1096-9098(199803)67:3<194::aid-jso11>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  2. Cawthorn S. J., Gibbs N. M., Marks C. G. Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg. 1986 Jan;73(1):58–60. doi: 10.1002/bjs.1800730124. [DOI] [PubMed] [Google Scholar]
  3. Cutait R., Alves V. A., Lopes L. C., Cutait D. E., Borges J. L., Singer J., da Silva J. H., Goffi F. S. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum. 1991 Oct;34(10):917–920. doi: 10.1007/BF02049708. [DOI] [PubMed] [Google Scholar]
  4. Davidson B. R., Sams V. R., Styles J., Deane C., Boulos P. B. Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer. 1990 Feb 15;65(4):967–970. doi: 10.1002/1097-0142(19900215)65:4<967::aid-cncr2820650424>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  5. Demeure M. J., Doffek K. M., Komorowski R. A., Wilson S. D. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer. 1998 Oct 1;83(7):1328–1334. [PubMed] [Google Scholar]
  6. Fujiwara Y., Ooka M., Sugita Y., Sakita I., Tamaki Y., Monden M. Prevention of cross-contamination during sampling procedure in molecular detection for cancer micrometastasis. Cancer Lett. 2000 May 29;153(1-2):109–111. doi: 10.1016/s0304-3835(00)00355-4. [DOI] [PubMed] [Google Scholar]
  7. Funaki N. O., Tanaka J., Ohshio G., Onodera H., Maetani S., Imamura M. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer. 1998 Apr;77(8):1327–1332. doi: 10.1038/bjc.1998.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Futamura M., Takagi Y., Koumura H., Kida H., Tanemura H., Shimokawa K., Saji S. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol. 1998 May;68(1):34–40. doi: 10.1002/(sici)1096-9098(199805)68:1<34::aid-jso8>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  9. Gerhard M., Juhl H., Kalthoff H., Schreiber H. W., Wagener C., Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol. 1994 Apr;12(4):725–729. doi: 10.1200/JCO.1994.12.4.725. [DOI] [PubMed] [Google Scholar]
  10. Henke W., Loening S. A. Detection of illegitimate transcripts of prostate-specific antigen mRNA in blood by reverse transcription-polymerase chain reaction. Int J Cancer. 1998 Jul 3;77(1):164–165. doi: 10.1002/(sici)1097-0215(19980703)77:1<164::aid-ijc25>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  11. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg. 1995 Mar-Apr;19(2):184–190. doi: 10.1007/BF00308624. [DOI] [PubMed] [Google Scholar]
  12. Jung R., Petersen K., Krüger W., Wolf M., Wagener C., Zander A., Neumaier M. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer. 1999 Nov;81(5):870–873. doi: 10.1038/sj.bjc.6690778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liefers G. J., Cleton-Jansen A. M., van de Velde C. J., Hermans J., van Krieken J. H., Cornelisse C. J., Tollenaar R. A. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 1998 Jul 23;339(4):223–228. doi: 10.1056/NEJM199807233390403. [DOI] [PubMed] [Google Scholar]
  14. Moll R., Löwe A., Laufer J., Franke W. W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992 Feb;140(2):427–447. [PMC free article] [PubMed] [Google Scholar]
  15. Mori M., Mimori K., Inoue H., Barnard G. F., Tsuji K., Nanbara S., Ueo H., Akiyoshi T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995 Aug 1;55(15):3417–3420. [PubMed] [Google Scholar]
  16. Mori M., Mimori K., Ueo H., Tsuji K., Shiraishi T., Barnard G. F., Sugimachi K., Akiyoshi T. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol. 1998 Jan;16(1):128–132. doi: 10.1200/JCO.1998.16.1.128. [DOI] [PubMed] [Google Scholar]
  17. Natsugoe S., Mueller J., Stein H. J., Feith M., Höfler H., Siewert J. R. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer. 1998 Sep 1;83(5):858–866. [PubMed] [Google Scholar]
  18. Neumaier M., Gerhard M., Wagener C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene. 1995 Jun 14;159(1):43–47. doi: 10.1016/0378-1119(94)00522-t. [DOI] [PubMed] [Google Scholar]
  19. Oberg A., Stenling R., Tavelin B., Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum. 1998 Oct;41(10):1244–1249. doi: 10.1007/BF02258221. [DOI] [PubMed] [Google Scholar]
  20. Raj G. V., Moreno J. G., Gomella L. G. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer. 1998 Apr 15;82(8):1419–1442. doi: 10.1002/(sici)1097-0142(19980415)82:8<1419::aid-cncr1>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  21. Ratto C., Sofo L., Ippoliti M., Merico M., Doglietto G. B., Crucitti F. Prognostic factors in colorectal cancer. Literature review for clinical application. Dis Colon Rectum. 1998 Aug;41(8):1033–1049. doi: 10.1007/BF02237397. [DOI] [PubMed] [Google Scholar]
  22. Ruo L., Guillem J. G. Surgical management of primary colorectal cancer. Surg Oncol. 1998 Nov-Dec;7(3-4):153–163. doi: 10.1016/s0960-7404(99)00033-x. [DOI] [PubMed] [Google Scholar]
  23. Ruud P., Fodstad O., Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer. 1999 Jan 5;80(1):119–125. doi: 10.1002/(sici)1097-0215(19990105)80:1<119::aid-ijc22>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  24. Schrewe H., Thompson J., Bona M., Hefta L. J., Maruya A., Hassauer M., Shively J. E., von Kleist S., Zimmermann W. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression. Mol Cell Biol. 1990 Jun;10(6):2738–2748. doi: 10.1128/mcb.10.6.2738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Steele G. D., Jr The National Cancer Data Base report on colorectal cancer. Cancer. 1994 Oct 1;74(7):1979–1989. doi: 10.1002/1097-0142(19941001)74:7<1979::aid-cncr2820740725>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  26. Yun K., Merrie A. E., Gunn J., Phillips L. V., McCall J. L. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations. J Pathol. 2000 May;191(1):21–26. doi: 10.1002/(SICI)1096-9896(200005)191:1<21::AID-PATH581>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  27. Zhang P. J., Reisner R. M., Nangia R., Edge S. B., Brooks J. J. Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer: a retrospective study with immunohistochemical analysis. Arch Pathol Lab Med. 1998 Aug;122(8):687–690. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES